Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial.

guest :: login DKFZ
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications database > Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial. > Access to Fulltext

Information
Files

Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial. - DKFZ-2025-02052

Main document file(s):

Similar records

DKFZ :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy